On Thursday, Ericsson (ADR) (NASDAQ:ERIC)’s shares inclined 1.23% to $9.85.
Global leaders in the mobile and enterprise industries, Ericsson (ERIC), Hewlett-Packard (HPQ) and Aruba Netoperates, an HP company, are joining forces to drive innovation in mobile networking. The companies will bring to market a ground-breaking set of Wi-Fi and LTE solutions providing customers with ubiquitous voice and data connectivity.
There is a rapidly growing need to maximize the benefits of licensed and unlicensed spectrum operating together in the Enterprise. To capture this business opportunity, Ericsson is incorporating Aruba`s 802.11ac enterprise Wi-Fi technology into the Ericsson RBS 6402 indoor picocell. Carrying the Ericsson brand, the solution will work seamlessly with the rest of the Aruba Wi-Fi portfolio and with the Ericsson radio access network to deliver users pervasive connectivity indoors.
Ericsson and HP have also signed bilateral resale agreements. Ericsson can offer Aruba`s enterprise Wi-Fi and connectivity solutions together with Ericsson`s portfolio of mobility solutions and global services to customers worldwide. Additionally, these agreements allow HP to resell Ericsson`s industry-leading licensed band indoor small cell solutions, and bring the full value of licensed and unlicensed mobile networking to HP`s global base of enterprise customers.
Ericsson provides communications technology and services worldwide. The company’s Netoperates segment delivers products and solutions for mobile access, Internet protocol (IP) and transmission netoperates, core netoperates, and cloud.
Joy Global Inc. (NYSE:JOY)’s shares dropped -1.36% to $18.49.
Joy Global Inc. (JOY), a worldwide leader in high-productivity mining solutions, recently stated third quarter fiscal 2015 results.
Third Quarter Summary
- Bookings $635 million, down 31 percent from a year ago.
- Service bookings $537 million, down 16 percent from a year ago.
- Net sales $792 million, down 10 percent from a year ago.
- Earnings per diluted share $0.46, contrast to $0.71 a year ago.
- Not Taking Into Account excess purchase accounting, acquisition costs, restructuring charges and pension items of $14 million, adjusted earnings per diluted share of $0.54, contrast to $0.80 a year ago.
- Net cash offered by operations $116 million, up 27% from a year ago.
Third Quarter Operating Results
Merged bookings in the third quarter totaled $635 million, a decrease of 31 percent as compared to the third quarter of last year. Original equipment orders reduced 66 percent while service orders were down 16 percent contrast to the preceding year. Bookings were reduced by $46 million from the impact of foreign currency exchange movements as compared to the year ago period, a $2 million decrease for original equipment and a $44 million decrease for service bookings. When adjusting for foreign currency exchange, orders were down 26 percent contrast to the third quarter of last year, with original equipment orders down 65 percent and service orders down 9 percent.
Joy Global Inc. manufactures and services mining equipment for the extraction of coal, copper, iron ore, oil sands, gold, and other minerals. It operates in two segments, Underground Mining Machinery and Surface Mining Equipment.
At the end of Thursday’s trade, GlaxoSmithKline plc (ADR) (NYSE:GSK)‘s shares dipped -0.23% to $40.42.
GlaxoSmithKline plc GSK) and Theravance, Inc. (THRX) recently initial results from the Study to Understand Mortality and MorbidITy in COPD (SUMMIT) for Relvar®/Breo® Ellipta® 100/25mcg (fluticasone furoate ‘FF’/vilanterol ‘VI’ or ‘FF/VI’). The study involved 16,485 patients from 43 countries who had chronic obstructive pulmonary disease (COPD) with moderate airflow limitation (FEV1 50-70% predicted) and either a history or raised risk of cardiovascular disease (CVD).
For the primary endpoint of the study, the risk of dying on FF/VI 100/25mcg was 12.2% lower than on placebo* over the study period, which was not statistically noteworthy(p=0.137).
For the first of two secondary endpoints, FF/VI 100/25mcg reduced the rate of lung function decline (as measured by forced expiratory volume in one second, ‘FEV1’) by 8mL per year contrast with placebo (p=0.019). As the primary endpoint was not met, statistical significance cannot be inferred from this result. For the other secondary endpoint, the risk of experiencing an on-treatment cardiovascular (CV) event (CV death, myocardial infarction, stroke, unstable angina and transient ischemic attack [TIA]) at any time was 7.4% lower in patients taking FF/VI 100/25mcg as compared to placebo which was not statistically noteworthy(p=0.475).
GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, counting vaccines, over-the-counter medicines, and health-related consumer products worldwide.
ON Semiconductor Corp (NASDAQ:ON), ended its Thursday’s trading session with -0.78% loss, and closed at $10.17.
Bio-on and Moore Capital signed a license agreement to build the first Brazil-based facility to produce PHAs bioplastic from sugar cane co-products.
The two companies, operating in sustainable biochemistry and in the development of eco-sustainable industrial solutions, will work together to build a production site with a 10 thousand tons/year output, in the state of São Paulo and/or Acre State. Requiring an 80 million Euro investment, the facility will be the most advanced biopolymers production site in South America. The new production hub will create 60 new jobs plus allied industries, assisting to meet the high demand for this revolutionary biopolymer already coming in from numerous companies that transform or produce conventional plastic in Brazil.
PHAs, or polyhydroxyalkanoates, are bioplastics that can replace a number of traditional polymers presently made with petrochemical processes using hydrocarbons. The PHAs developed by Bio-on guarantee the same thermo-mechanical properties with the advantage of being completely naturally biodegradable.
ON Semiconductor Corporation manufactures and sells semiconductor components for various electronic devices worldwide. It operates in four segments: Application Products Group, Image Sensor Group, Standard Products Group, and System Solutions Group.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
